Umeclidinium and Vilanterol Trifenatate
Anoro Ellipta, Umeclidinium and Vilanterol Ellipta
NADAC/unit
$4.9169
No Shortage
Tier 1: 15.8%
vs. brand Anoro Ellipta: Generic saves up to 51% per unit
Market Intelligence
2024-01-03 Class III Recall: GlaxoSmithKline LLC
Generic Manufacturers
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.